ASX
Imugene Limited
IMU:ASX•Healthcare
Sensitive ASX Announcement
Imugene Commences Cohort 2 Dosing in Phase 1 PD1-VAXX Trial
Published: 12/02/21, 08:41am (AEST)•2 pages